Cargando…
Identification of Serum Interleukin 6 Levels as a Disease Severity Biomarker in Facioscapulohumeral Muscular Dystrophy
BACKGROUND: Facioscapulohumeral muscular dystrophy (FSHD) is one of the most common myopathies in adults, displaying a progressive, frequently asymmetric involvement of a typical muscles’ pattern. FSHD is associated with epigenetic derepression of the polymorphic D4Z4 repeat on chromosome 4q, leadin...
Autores principales: | Gros, Marilyn, Nunes, Andreia M., Daoudlarian, Douglas, Pini, Jonathan, Martinuzzi, Emanuela, Barbosa, Susana, Ramirez, Monique, Puma, Angela, Villa, Luisa, Cavalli, Michele, Grecu, Nicolae, Garcia, Jérémy, Siciliano, Gabriele, Solé, Guilhem, Juntas-Morales, Raul, Jones, Peter L., Jones, Takako, Glaichenhaus, Nicolas, Sacconi, Sabrina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842759/ https://www.ncbi.nlm.nih.gov/pubmed/34459413 http://dx.doi.org/10.3233/JND-210711 |
Ejemplares similares
-
Identification of candidate miRNA biomarkers for facioscapulohumeral muscular dystrophy using DUX4-based mouse models
por: Nunes, Andreia M., et al.
Publicado: (2021) -
The French National Registry of patients with Facioscapulohumeral muscular dystrophy
por: Guien, Céline, et al.
Publicado: (2018) -
A cre-inducible DUX4 transgenic mouse model for investigating facioscapulohumeral muscular dystrophy
por: Jones, Takako, et al.
Publicado: (2018) -
Convergence of patient- and physician-reported outcomes in the French National Registry of Facioscapulohumeral Dystrophy
por: Sanson, Benoît, et al.
Publicado: (2022) -
Identification of Epigenetic Regulators of DUX4-fl for Targeted Therapy of Facioscapulohumeral Muscular Dystrophy
por: Himeda, Charis L., et al.
Publicado: (2018)